0 false false false false false false false false false false true true false false false false false 2022-04-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 10886882 2022-04-01 2023-03-31 10886882 2023-03-31 10886882 2022-03-31 10886882 2021-04-01 2022-03-31 10886882 2022-03-31 10886882 2021-03-31 10886882 bus:RegisteredOffice 2022-04-01 2023-03-31 10886882 bus:Director1 2022-04-01 2023-03-31 10886882 bus:Director2 2022-04-01 2023-03-31 10886882 core:ShareCapital 2023-03-31 10886882 core:ShareCapital 2022-03-31 10886882 bus:SmallEntities 2022-04-01 2023-03-31 10886882 bus:AuditExempt-NoAccountantsReport 2022-04-01 2023-03-31 10886882 bus:SmallCompaniesRegimeForAccounts 2022-04-01 2023-03-31 10886882 bus:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31 10886882 bus:FullAccounts 2022-04-01 2023-03-31
COMPANY REGISTRATION NUMBER: 10886882
Bioganix (Welland) Limited
Unaudited Financial Statements
For the year ended
31 March 2023
Bioganix (Welland) Limited
Financial Statements
Year ended 31 March 2023
Contents
Page
Directors' report
1
Statement of financial position
2
Notes to the financial statements
3
Bioganix (Welland) Limited
Directors' Report
Year ended 31 March 2023
The directors present their report and the unaudited financial statements of the company for the year ended 31 March 2023 .
Principal activities
The principal activity of the company during the 2021 year was that of waste disposal, digestate recycling, treatment for oil recovery and energy generation. The company ceased trading on 31 March 2021 and has remained dormant since that date.
Directors
The directors who served the company during the year were as follows:
L M Dodds
C D Tyler
Small company provisions
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
This report was approved by the board of directors on 15 March 2024 and signed on behalf of the board by:
L M Dodds
Director
Registered office:
Bonby Lane
Bonby
Brigg
North Lincolnshire
DN20 0PJ
Bioganix (Welland) Limited
Statement of Financial Position
31 March 2023
2023
2022
Note
£
£
£
Current assets
Debtors
4
100
100
----
----
Net current assets
100
100
----
----
Total assets less current liabilities
100
100
----
----
Capital and reserves
Called up share capital
100
100
----
----
Shareholders funds
100
100
----
----
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
For the year ending 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 15 March 2024 , and are signed on behalf of the board by:
L M Dodds
Director
Company registration number: 10886882
Bioganix (Welland) Limited
Notes to the Financial Statements
Year ended 31 March 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Bonby Lane, Bonby, Brigg, North Lincolnshire, DN20 0PJ.
2. Statement of compliance
These financial statements have been prepared in compliance with FRS 102 Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
(a) Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.
(b) Current and deferred tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to be paid or recovered using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
(c) Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities .
4. Debtors
2023
2022
£
£
Amounts owed by group undertakings
100
100
----
----
5. Related party transactions
The company has taken advantage of the exemptions provided in FRS 102 from reporting transactions between wholly owned members of the group.
6. Controlling party
For the entire period, the parent company was Bioganix Ltd , a company registered in England and Wales. The registered office address of Bioganix Ltd is Bonby Lane, Bonby, Brigg, North Lincolnshire, DN20 0PJ.